Παρασκευή 12 Αυγούστου 2016

DRUG UTILISATION PATTERN IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A TERTIARY CARE TEACHING HOSPITAL

2016-08-12T02-13-49Z
Source: Indo American Journal of Pharmaceutical Research
Vikneswari,, T. Tamizh Mani*.
Chronic Respiratory Diseases (CRD) such as Chronic Obstructive Pulmonary Disease (COPD) may account for an estimated burden of about 100 million individuals in India. The technique of drug utilization review (DUR) can provide useful means of determining whether drug use is as appropriate in treatment of individual patients. This was a Prospective study with the aim of analyse the drug prescribing pattern in Chronic obstructivepulmonary disease patients and the prescribing parameters in the collected prescription. The study has been conducted on male and female patients who were satisfying the inclusion criteria. A suitably designed case record form was prepared and used to record all the necessary and relevant data from the medical records of patients. A total of 250 patients were analysed in our study. Out of that 188 were males and 62 were females. The prescription of more than 3 drugs for one patient may be attributed to the possibility of some patients presenting with acute and chronic exacerbation of COPD with or without co-morbid conditions, which requires antibiotic and corticosteroid treatment. Antibiotics were mostly prescribed (19.2%), followed by anticholinergics (18.70%). Inhalation route (38.32%) was more preferred over parenteral (37.98%) and oral route (23.70%). In our study, we observed that the incidence of COPD was more common in males when compared to females. The majority of patients have intermittent exacerbations of COPD due to the inadequate pattern of drug use. GOLD guidelines can be properly followed for prescribing drugs for COPD and can be achieve total control of COPD.


from Scope via xlomafota13 on Inoreader http://ift.tt/2baF0El
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.